Skip to main content
Clinical Trials/NCT06168253
NCT06168253CompletedNot Applicable

Text Message Safety Behavior Fading Intervention for Social Anxiety

Florida State University1 site in 1 country201 target enrollmentStarted: January 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
201
Locations
1
Primary Endpoint
Change in Social Phobia Inventory (SPIN)

Study Overview

Brief Summary

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

Detailed Description

Safety behavior fading may be a viable standalone intervention for social anxiety. In the present trial, participants high in social anxiety will be randomized to either receive a daily checklist exercise aimed at eliminating (1) safety behaviors or (2) unhealthy behaviors. Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their four most habitual social anxiety safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day. Individuals randomly assigned to the control condition will receive similar text messages and a daily checklist to encourage fading of unhealthy behaviors. Participants in both conditions will complete checklists for 28 days. After day 14 of treatment, participants will re-select their target safety behaviors or unhealthy behaviors, and will then be prompted to reduce these new behaviors for another 14 days.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

Participants will receive one of two matched interventions. They will not be told whether they are receiving the active or control intervention.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Social Phobia Inventory Score >29
  • •Stable Psychotropic Medications for 4 weeks prior to participation

Exclusion Criteria

  • •Currently participating in psychotherapy for social anxiety

Arms & Interventions

Experimental: Safety Behavior Fading

Experimental

This treatment lasts a total of 28 days. Participants will be asked to identify common safety behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target safety behaviors and continue to reduce them over the next two weeks.

Intervention: Safety Behavior Fading for Social Anxiety (Behavioral)

Unhealthy Behavior Fading

Active Comparator

This treatment lasts a total of 28 days. Participants will be asked to identify common unhealthy behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target unhealthy behaviors and continue to reduce them over the next two weeks.

Intervention: Unhealthy Behavior Fading (Behavioral)

Outcomes

Primary Outcomes

Change in Social Phobia Inventory (SPIN)

Time Frame: Time Frame: Day 0, Day 14, Day 28, Day 56

Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

Secondary Outcomes

  • Change in Self-Beliefs Related to Social Anxiety Scale (SBSA)(Time Frame: Day 0, Day 28, Day 56)
  • Change in Subtle Avoidance Frequency Examination (SAFE) scale(Time Frame: Day 0, Day 28, Day 56)
  • Change in Center For Epidemiological Studies Depression Scale, Ten Item Version (CESD-10)(Time Frame: Day 0, Day 28, Day 56)
  • Change in UCLA Loneliness Scale, Short Form (ULS-8)(Time Frame: Day 0, Day 28, Day 56)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jesse Cougle

Principal Investigator

Florida State University

Study Sites (1)

Loading locations...

Similar Trials